Andrew R. Robbins - President and CEO, Director at Cogent Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
COGT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew R. Robbins since 08 Jan 2025

Holdings reported by Andrew R. Robbins for Cogent Biosciences, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 657,503 $25,938,493 $39.45 17 Dec 2025 Direct
Stock Option (Right to Buy) 245,000 17 Dec 2025 Direct Common Stock

Transactions reported by Andrew R. Robbins for Cogent Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.